PRINCIPAL FINANCIAL GROUP INC

Position in GPCR — Structure Therapeutics Inc.

CIK 1126328 DES MOINES, IA

Position in GPCR

as of Mar 31, 2026 · filed May 4, 2026 Compact

Position Value

$84,531,424

-$4,785,381 QoQ

Shares Held

1,753,764

+36.6% QoQ

Ownership

0.823%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

PRINCIPAL FINANCIAL GROUP INC holds $1,683,587,850 across 95 Biotechnology names. GPCR ranks #6 (5.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ASND	Ascendis Pharma A/S	896,397	$205,032,885
2	VRTX	Vertex Pharmaceuticals Inc / Ma	426,523	$190,459,579
3	INSM	INSMED Inc	916,464	$149,860,192
4	BBIO	BridgeBio Pharma, Inc.	1,330,415	$98,796,617
5	REGN	Regeneron Pharmaceuticals, Inc.	120,425	$93,045,171
6	GPCR	Structure Therapeutics Inc. This page	1,753,764	$84,531,424
7	CYTK	Cytokinetics Inc	1,093,485	$72,071,595
8	AXSM	Axsome Therapeutics, Inc.	350,488	$59,239,481

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$84,531,424	1,753,764	+36.6%	Shares	Defined	2026-05-04
2025-12-31	$89,316,805	1,284,210	+63.1%	Shares	Defined	2026-02-02
2025-09-30	$22,049,552	787,484	-7.7%	Shares	Defined	2025-11-04
2025-06-30	$17,695,409	853,202	+12.8%	Shares	Defined	2025-08-08
2025-03-31	$13,098,598	756,707	-4.4%	Shares	Defined	2025-04-28
2024-12-31	$21,455,553	791,134	+45.1%	Shares	Defined	2025-01-31
2024-09-30	$23,935,806	545,359	+230.0%	Shares	Defined	2024-12-19
2024-06-30	$6,489,131	165,244	—	Shares	Defined	2024-07-29
No filing history on record for this holder in this stock.